While injection-site irritation is well recognized, clinicians are increasingly observing broader skin changes in patients treated with semaglutide (Ozempic, Wegovy), liraglutide (Victoza, Saxenda), and tirzepatide Read More GLP-1s and Dermatologic Reactions: Beyond Injection-Site Effects Dermatologic reactions linked to GLP-1 therapy are gaining attention as the use of glucagon-like peptide-1 receptor agonists continues to expand in diabetes and obesity care
Acupressure, a non-invasive form of acupuncture, can also be used to manage nausea
DOI: 10.1016/j.bbabio.2009.02.001 19
Participants in the tablet trial lost an average of 13.6% of body weight at 64 weeks, while those in the injection trial lost 14.9% at 68 weeks
Microwave, eat, and know exactly what went into your body
This is safe, moderate weight loss that I think most of our patients with obesity require, said lead study author W